HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Solomon, A M Articles by Bouloux, P M G Search for Related Content PubMed PubMed Citation Articles by Solomon, A M Articles by Bouloux, P M G

Department of Endocrinology, Royal Free Hospital and Medical School, Pond Street, London NW3 2PF, UK

(Requests for offprints should be addressed to A M Solomon; Email: a.solomon{at}medsch.ucl.ac.uk)

This review describes the major hormonal factors that determine the balance between human skeletal muscle anabolism and catabolism in health and disease, with specific reference to age-related muscle loss (sarcopenia). The molecular mechanisms associated with muscle hypertrophy are described, and the central role of the satellite cell highlighted. The biological dynamics of satellite cells, varying between states of quiescence, proliferation and differentiation are strongly influenced by local endocrine factors. The molecular mechanisms of muscle atrophy are examined focussing on the causes of sarcopenia and associations with systemic medical disorders. In addition, evidence is provided that the mechanisms of atrophy and hypertrophy are unlikely to be simple opposites. Novel endocrine mechanisms underpinning mechano-transduction include IGF-I subtypes that may differentiate between endocrine and mechanical signals; their interaction with classical endocrine factors is an active area of translational research. Recently acquired knowledge on the mechanism of anabolic effects of androgens is also reviewed. The increasingly recognised role of myostatin, a negative regulator of muscle function, is described, as well as its potential as a therapeutic target. Strategies to counter age-related sarcopenia thus represent an exciting field of future investigation.

This article has been cited by other articles:

				G. L. Jensen Inflammation: Roles in Aging and Sarcopenia JPEN J Parenter Enteral Nutr, November 1, 2008; 32(6): 656 - 659. [Abstract] [Full Text] [PDF]

				W. G. Bergen Measuring in vivo intracellular protein degradation rates in animal systems J Anim Sci, April 1, 2008; 86(14_suppl): E3 - E12. [Abstract] [Full Text] [PDF]

				R. A. Dennis, B. Przybyla, C. Gurley, P. M. Kortebein, P. Simpson, D. H. Sullivan, and C. A. Peterson Aging alters gene expression of growth and remodeling factors in human skeletal muscle both at rest and in response to acute resistance exercise Physiol Genomics, February 19, 2008; 32(3): 393 - 400. [Abstract] [Full Text] [PDF]

				K. Hojlund, Z. Yi, H. Hwang, B. Bowen, N. Lefort, C. R. Flynn, P. Langlais, S. T. Weintraub, and L. J. Mandarino Characterization of the Human Skeletal Muscle Proteome by One-dimensional Gel Electrophoresis and HPLC-ESI-MS/MS Mol. Cell. Proteomics, February 1, 2008; 7(2): 257 - 267. [Abstract] [Full Text] [PDF]

				S. D. R. Harridge Plasticity of human skeletal muscle: gene expression to in vivo function Exp Physiol, September 1, 2007; 92(5): 783 - 797. [Abstract] [Full Text] [PDF]